Free Trial

Investors Buy High Volume of Call Options on Teladoc Health (NYSE:TDOC)

Teladoc Health logo with Medical background

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the target of some unusual options trading activity on Thursday. Traders purchased 28,801 call options on the company. This represents an increase of 61% compared to the average volume of 17,846 call options.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Citigroup lowered their price objective on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Bank of America lowered their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday, May 28th. Piper Sandler reduced their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Finally, Wells Fargo & Company dropped their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Teladoc Health presently has an average rating of "Hold" and a consensus target price of $9.60.

Check Out Our Latest Research Report on TDOC

Insider Activity at Teladoc Health

In other news, insider Fernando M. Rodrigues sold 4,174 shares of the company's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,667 shares of company stock worth $220,901. 0.58% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

Institutional investors and hedge funds have recently modified their holdings of the business. Golden State Wealth Management LLC raised its stake in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its stake in Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares in the last quarter. Whipplewood Advisors LLC purchased a new position in Teladoc Health during the 4th quarter worth $29,000. Lindbrook Capital LLC raised its position in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Finally, SVB Wealth LLC purchased a new stake in shares of Teladoc Health in the 1st quarter worth $37,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Stock Performance

Shares of NYSE TDOC traded up $0.20 during midday trading on Tuesday, hitting $7.07. 4,754,616 shares of the stock traded hands, compared to its average volume of 6,258,683. The firm has a market capitalization of $1.24 billion, a P/E ratio of -1.22 and a beta of 1.82. Teladoc Health has a one year low of $6.35 and a one year high of $15.21. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a 50-day moving average of $7.23 and a two-hundred day moving average of $9.19.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Stories

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines